Company develops blood tests for psychiatric diseases

Rules Based Medicine is developing what it says is the first blood test for schizophrenia. The test, called VeriPsych, was developed with Cambridge University and relies on 51 biomarkers.

Since the company's launch six months ago, psychiatrists have ordered the test for about 500 patients. "There's not so much resistance as trepidation," VeriPsych Chief Medical Officer Michael Spain told Fast Company. "Physicians that routinely do lab tests understand that [the doctor] puts it all together and makes the diagnosis. Psychiatrists have it in their minds that the test makes the diagnosis."

The magazine says VeriPsych plans to also develop blood tests for major depression and bipolar disorder.

- get more from Fast Company

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.